Company name: Bi02 Medical Inc.
Industry: medical devices.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Location: San Antonio, Texas.
Solution/product: The Angel Catheter is a “central venous catheter and inferior vena cava (IVC) filter combination device” that is designed to prevent pulmonary embolism in critically ill patients.
Money raised: $12 million in series C financing.
How it will be used: to commercialize the Angel Catheter.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Investors: Remeditex Ventures, Incyte Ventures Targeted Technology Fund.
Management team: Christopher Banas, chairman and CEO; Luis Angel, chief medical officer; Paul Castella, chief financial officer.
Market: Currently the market for retrievable IVC filters like the Angel Catheter is about $250 million and growing at 11 percent annually, according to the company. There are several players in the space including Peripheral Vascular, Cordis Corporation (a division of Johnson & Johnson), Boston Scientific Corporation and Cook Medical. A 2007 study found that more than half of all diagnosed cases of pulmonary embolism occurs in patients who are in hospitals or nursing homes.
[Photo Credit: freedigitalphotos user Salvatore Vuono]
